InvestmentJun 11, 2026, 08:01 PM
Arcadia Biosciences Raises $4M in Private Placement
AI Summary
Arcadia Biosciences, Inc. announced it has entered into securities purchase agreements for a private placement expected to generate approximately $4 million in gross proceeds. The offering includes 3,883,496 shares of its common stock (or pre-funded warrants) and associated Series A-1 and Series A-2 preferred investment options, priced at $1.03 per share. The net proceeds from this offering will be utilized for working capital and general corporate purposes.
Key Highlights
- Arcadia Biosciences raised approximately $4 million in gross proceeds from a private placement.
- The offering includes 3,883,496 shares of common stock or pre-funded warrants.
- It also includes Series A-1 and Series A-2 preferred investment options.
- The purchase price for shares/warrants and options is $1.03 per unit.
- Series A-1 and A-2 preferred investment options have an exercise price of $0.91 per share.
- Net proceeds will be used for working capital and general corporate purposes.
Price Impact
More from RKDA